Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation
<p>Abstract</p> <p>We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. Compared to previ...
Main Authors: | Farnsworth Paul, Ward David, Reddy Vijay |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | http://www.ehoonline.org/content/1/1/29 |
Similar Items
-
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
by: Robert Puckrin, et al.
Published: (2023-01-01) -
The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy
by: Katie Maurer, et al.
Published: (2024-03-01) -
Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01) -
Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01) -
Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome
by: Hiroki Hosoi, et al.
Published: (2018-09-01)